JPS5817167B2 - 抗ウイルス作用を有する医薬組成物 - Google Patents

抗ウイルス作用を有する医薬組成物

Info

Publication number
JPS5817167B2
JPS5817167B2 JP55157971A JP15797180A JPS5817167B2 JP S5817167 B2 JPS5817167 B2 JP S5817167B2 JP 55157971 A JP55157971 A JP 55157971A JP 15797180 A JP15797180 A JP 15797180A JP S5817167 B2 JPS5817167 B2 JP S5817167B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
salt
compound
acid
antiviral action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55157971A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5781411A (en
Inventor
山口和夫
持田英
大西治夫
鈴木泰雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP55157971A priority Critical patent/JPS5817167B2/ja
Priority to JP56096376A priority patent/JPS58914A/ja
Priority to GB8133392A priority patent/GB2090136B/en
Priority to DE19813144689 priority patent/DE3144689A1/de
Priority to FR8121017A priority patent/FR2493702A1/fr
Publication of JPS5781411A publication Critical patent/JPS5781411A/ja
Priority to PCT/JP1982/000242 priority patent/WO1983000013A1/ja
Priority to EP82105460A priority patent/EP0068408A1/en
Publication of JPS5817167B2 publication Critical patent/JPS5817167B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP55157971A 1980-11-10 1980-11-10 抗ウイルス作用を有する医薬組成物 Expired JPS5817167B2 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP55157971A JPS5817167B2 (ja) 1980-11-10 1980-11-10 抗ウイルス作用を有する医薬組成物
JP56096376A JPS58914A (ja) 1980-11-10 1981-06-22 抗ウイルス作用を有する医薬組成物
GB8133392A GB2090136B (en) 1980-11-10 1981-11-05 Antiviral compositions containing sulphonamide derivatives
DE19813144689 DE3144689A1 (de) 1980-11-10 1981-11-10 Antivirusmittel
FR8121017A FR2493702A1 (fr) 1980-11-10 1981-11-10 Compositions antivirales contenant des derives d'acide aminosulfonylhalogenobenzoique
PCT/JP1982/000242 WO1983000013A1 (en) 1980-11-10 1982-06-22 Medicinal composition having an antiviral effect
EP82105460A EP0068408A1 (en) 1980-11-10 1982-06-22 Antiviral compositions and a method for treating virus diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55157971A JPS5817167B2 (ja) 1980-11-10 1980-11-10 抗ウイルス作用を有する医薬組成物
JP56096376A JPS58914A (ja) 1980-11-10 1981-06-22 抗ウイルス作用を有する医薬組成物

Publications (2)

Publication Number Publication Date
JPS5781411A JPS5781411A (en) 1982-05-21
JPS5817167B2 true JPS5817167B2 (ja) 1983-04-05

Family

ID=26437582

Family Applications (2)

Application Number Title Priority Date Filing Date
JP55157971A Expired JPS5817167B2 (ja) 1980-11-10 1980-11-10 抗ウイルス作用を有する医薬組成物
JP56096376A Pending JPS58914A (ja) 1980-11-10 1981-06-22 抗ウイルス作用を有する医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP56096376A Pending JPS58914A (ja) 1980-11-10 1981-06-22 抗ウイルス作用を有する医薬組成物

Country Status (4)

Country Link
JP (2) JPS5817167B2 (enrdf_load_stackoverflow)
DE (1) DE3144689A1 (enrdf_load_stackoverflow)
FR (1) FR2493702A1 (enrdf_load_stackoverflow)
GB (1) GB2090136B (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6189887A (ja) * 1984-10-09 1986-05-08 Hosokawa Katsupanshiyo:Kk 感熱熱転写用原紙
JPS61188866U (enrdf_load_stackoverflow) * 1985-05-16 1986-11-25

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58192820A (ja) * 1982-05-06 1983-11-10 Mochida Pharmaceut Co Ltd 抗ウイルス作用を有する医薬組成物
EP0068408A1 (en) * 1980-11-10 1983-01-05 Mochida Pharmaceutical Co., Ltd. Antiviral compositions and a method for treating virus diseases
EP0132540A1 (en) * 1981-06-22 1985-02-13 Mochida Pharmaceutical Co., Ltd. Antiviral compositions
DK315482A (da) * 1981-07-20 1983-01-21 Kimberly Clark Co Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden
EP0197386B1 (en) * 1985-03-27 1988-11-02 Merck & Co. Inc. 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them
ZA92970B (en) * 1991-02-12 1992-10-28 Hoechst Ag Arylsulfonylureas,processes for their preparation,and their use as herbicides and growth regulators
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6189887A (ja) * 1984-10-09 1986-05-08 Hosokawa Katsupanshiyo:Kk 感熱熱転写用原紙
JPS61188866U (enrdf_load_stackoverflow) * 1985-05-16 1986-11-25

Also Published As

Publication number Publication date
DE3144689A1 (de) 1982-07-22
JPS58914A (ja) 1983-01-06
JPS5781411A (en) 1982-05-21
GB2090136B (en) 1985-02-06
FR2493702B1 (enrdf_load_stackoverflow) 1984-10-12
FR2493702A1 (fr) 1982-05-14
GB2090136A (en) 1982-07-07

Similar Documents

Publication Publication Date Title
US4215113A (en) Method for combating virus infections
US4452800A (en) Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
JPS5817167B2 (ja) 抗ウイルス作用を有する医薬組成物
US2816059A (en) N-[beta-(o-chlorophenyl)-beta-(hydroxy)-ethyl] isopropyl amine, salts thereof, and compositions containing same
CA1297033C (en) Use of carboxylic acid amides for treating inflammations
US5545632A (en) Method of treating retroviral disease
CA1261265A (en) METHOD OF MEDICAL TREATMENT OF HUMAN VIRAL DISEASES UTILIZING 1-.beta.-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3- CARBOXAMIDE
JPS6333332A (ja) エイズ・ウイルス増殖抑制剤
US6492352B1 (en) Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
Diana et al. Chemotherapy of virus diseases
WO1990003172A2 (en) Bile acids for treatment of viral infections
US3857951A (en) Use of 2-mercaptopropionylglycine and its alkali metal salts in treating respiratory diseases
EP0623623B1 (en) 2-aminoethanesulfonic acid/zinc complex
JP2520252B2 (ja) グリチルリチン誘導体
EP0646586B1 (en) 2-aminoethanesulfonic acid/zinc complex compound
US20090041681A1 (en) Anti-inflammatory inhalation pharmaceutical composition
EP0486921A1 (en) N-acetyl-L-cysteine magnesium salt and pharmaceutical compositions containing it
US4243679A (en) S-(3-Methyl-2-butenyl)cysteine
JPH05213756A (ja) 抗インフルエンザ剤
EP0369776A2 (en) Use of a composition containing organic germanium for the manufacture of a medicament for treating AIDS
JPS63216820A (ja) 抗ウイルス剤
CN116077494A (zh) 一种治疗呼吸道合胞病毒的药物组合物及其制备方法
JPH0477428A (ja) エイズウィルス増殖抑制剤
US20050154060A1 (en) Anti-inflamatory inhalation pharmaceutical composition
JPS61204127A (ja) 抗ウイルス性化合物